Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Multiple Myeloma

This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients

Disease Sites: Multiple Myeloma

Phase: II

Investigator: Baljevic, Muhamed

NCTID: NCT05972135

Protocol No: VICCPCL24566

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form